Exposure to Perfluoroalkyl Chemicals and Cardiovascular Disease: Experimental and Epidemiological Evidence

Exposure to Perfluoroalkyl Chemicals and Cardiovascular Disease: Experimental and Epidemiological Evidence

Polyfluoro- and perfluoro–alkyl substances (PFAS) are organic chemicals extensively used worldwide for industry and consumer products. Due to their chemical stability, PFAS represent a major cause of environmental pollution. PFAS accumulate in animal and human blood and tissues exerting their toxici...

Full description

Bibliographic Details
Main Authors:	Alessandra Meneguzzi, Cristiano Fava, Marco Castelli, Pietro Minuz
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-07-01
Series:	Frontiers in Endocrinology
Subjects:	perfluoroalkyl substances cardiovascular disease obesity diabetes mellitus arterial hypertension platelets
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2021.706352/full

Similar Items

Maternal plasma perfluoroalkyl substances concentrations in early pregnancy and cardiovascular development in offspring: A prospective cohort study
by: Jian Wang, et al.
Published: (2023-03-01)

Environmental exposure to perfluoroalkyl substances in early pregnancy, maternal glucose homeostasis and the risk of gestational diabetes: A prospective cohort study
by: Guoqi Yu, et al.
Published: (2021-11-01)

All-cause, cardiovascular disease and cancer mortality in the population of a large Italian area contaminated by perfluoroalkyl and polyfluoroalkyl substances (1980–2018)
by: Annibale Biggeri, et al.
Published: (2024-04-01)

Perfluoroalkyl Substance Exposure and the BDNF Pathway in the Placental Trophoblast
by: Melissa J. Marchese, et al.
Published: (2021-07-01)

Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances
by: Lori Crawford, et al.
Published: (2023-02-01)

Associations of Perfluoroalkyl substances with blood lipids and Apolipoproteins in lipoprotein subspecies: the POUNDS-lost study
by: Gang Liu, et al.
Published: (2020-01-01)

Associations between Exposures to Perfluoroalkyl Substances and Diabetes, Hyperglycemia, or Insulin Resistance: A Scoping Review
by: Rachel Margolis, et al.
Published: (2021-09-01)

Exposure to Perfluoroalkyl Substances During Pregnancy and Fetal BDNF Level: A Prospective Cohort Study
by: Guoqi Yu, et al.
Published: (2021-06-01)

Association between perfluoroalkyl substance exposure and asthma and allergic disease in children as modified by MMR vaccination
by: Clara Amalie Gade Timmermann, et al.
Published: (2017-01-01)

Perfluoroalkyl substances exposure and immunity, allergic response, infection, and asthma in children: review of epidemiologic studies
by: Haley von Holst, et al.
Published: (2021-10-01)

Thyroid hormone levels in healthy adults with non-occupational exposure to cadmium， lead and perfluoroalkyl substances
by: YING Tao, et al.
Published: (2022-05-01)

Research progress on relationship between exposure to perfluoroalkyl and polyfluoroalkyl substances and allergic diseases
by: Jiangwei KONG, et al.
Published: (2023-10-01)

Research Progress of Perfluoroalkyl Substances in Edible Oil—A Review
by: Yingyi Han, et al.
Published: (2023-07-01)

Perfluoroalkyl and polyfluoroalkyl substances (PFAS): First survey in water samples from the Bogotá River, Colombia
by: Anyela Ramírez-Canon, et al.
Published: (2022-07-01)

The association between perfluoroalkyl substances and lipid profile in exposed pregnant women in the Veneto region, Italy
by: Teresa Dalla Zuanna, et al.
Published: (2021-02-01)

Perfluoroalkyl Substance Serum Concentrations and Cholesterol Absorption-Inhibiting Medication Ezetimibe
by: Ge Ma, et al.
Published: (2022-12-01)

Serum concentrations of perfluoroalkyl and polyfuoroalkyl substances and determinants in men of childbearing age
by: Jingyi HE, et al.
Published: (2023-09-01)

Associations between prenatal exposure to perfluoroalkyl substances and neurobehavioral development in early childhood: A prospective cohort study
by: Zhenzhen Xie, et al.
Published: (2022-08-01)

Aromatic and heterocyclic perfluoroalkyl sulfides. Methods of preparation
by: Vladimir N. Boiko
Published: (2010-08-01)

Perfluoroalkyl substances are associated with elevated blood pressure and hypertension in highly exposed young adults
by: Gisella Pitter, et al.
Published: (2020-09-01)

Aldosterone Biosynthesis Is Potently Stimulated by Perfluoroalkyl Acids: A Link between Common Environmental Pollutants and Arterial Hypertension
by: Brasilina Caroccia, et al.
Published: (2023-05-01)

Association between prenatal exposure to perfluoroalkyl substances and anogenital distance in female neonates
by: Jincan Li, et al.
Published: (2022-10-01)

Perfluoroalkyl Carboxylic Acids Interact with the Human Bile Acid Transporter NTCP
by: Melissa J. Ruggiero, et al.
Published: (2021-10-01)

Multiclass Determination of Endocrine-Disrupting Chemicals in Meconium: First Evidence of Perfluoroalkyl Substances in This Biological Compartment
by: Aritz Domínguez-Liste, et al.
Published: (2024-01-01)

Exposure to legacy and novel perfluoroalkyl substance disturbs the metabolic homeostasis in pregnant women and fetuses: A metabolome-wide association study
by: Yuqian Li, et al.
Published: (2021-11-01)

Perfluoroalkyl substances exposure in early pregnancy and preterm birth in singleton pregnancies: a prospective cohort study
by: Xiaona Huo, et al.
Published: (2020-06-01)

Exposure to perfluoroalkyl substances and blood pressure in pregnancy among 1436 women from the Odense Child Cohort
by: Anna Birukov, et al.
Published: (2021-06-01)

Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and childhood atopic dermatitis: a prospective birth cohort study
by: Qian Chen, et al.
Published: (2018-01-01)

Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women
by: Yanfeng Ren, et al.
Published: (2020-08-01)

Exploring the impact of prenatal perfluoroalkyl and polyfluoroalkyl substances exposure on blood pressure in early childhood: A longitudinal analysis
by: Bowen Du, et al.
Published: (2024-04-01)

Perfluoroalkyl substances and kidney function in chronic kidney disease, anemia, and diabetes
by: Conway BN, et al.
Published: (2018-11-01)

The Influence of Adiposity Levels on the Relation between Perfluoroalkyl Substances and High Depressive Symptom Scores in Czech Adults
by: Geraldo Neto, et al.
Published: (2023-11-01)

Study on serum perfluoroalkyl and polyfluoroalkyl substances exposure status of community residents in Songjiang District， Shanghai
by: LIANG Xinlei, et al.
Published: (2023-11-01)

Prenatal exposure to perfluoroalkyl substances and child intelligence quotient: Evidence from the Shanghai birth cohort
by: Hui Wang, et al.
Published: (2023-04-01)

Chain-length dependent ultrasonic degradation of perfluoroalkyl substances
by: Takshak Shende, et al.
Published: (2023-08-01)

Power density modulated ultrasonic degradation of perfluoroalkyl substances with and without sparging Argon
by: Takshak Shende, et al.
Published: (2021-08-01)

Prenatal and early postnatal exposure to perfluoroalkyl substances and bone mineral content and density in the Odense Child Cohort
by: Frederik Damsgaard Højsager, et al.
Published: (2023-11-01)

Prenatal and early postnatal exposure to perfluoroalkyl substances and bone mineral content and density in the Odense child cohort
by: F.D. Højsager, et al.
Published: (2022-09-01)

Poly- and Perfluoroalkyl Substances (PFAS): Do They Matter to Aquatic Ecosystems?
by: Sipra Nayak, et al.
Published: (2023-06-01)

Maternal co-exposure to mercury and perfluoroalkyl acid isomers and their associations with child neurodevelopment in a Canadian birth cohort
by: Anthony J.F. Reardon, et al.
Published: (2023-08-01)